FeesSafety
Pluang+

Cavco Industries Q2 revenue rises 17.9% on higher home sales, net income per share up 9%.

Company Fundamentals
29 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Cavco Industries Q2 revenue rises 17.9% on higher home sales, net income per share up 9%.

Cavco Industries reported a 17.9% increase in net revenue to $656.4 million for Q2 fiscal 2027, driven by a 15.3% rise in home sales volume and higher average selling prices. Net income per diluted share rose 9% to $7.17, supported by a one-time $7 million insurance premium return. Despite ongoing material cost pressures, selling price increases helped improve gross margins slightly. The company also noted growing backlogs and new opportunities in workforce housing, positioning it well for the coming months.

Cavco Industries' fiscal 2027 Q2 results provide context for consumer cyclical sector performance. For readers following this sector, here is Pluang's market snapshot as of Oct 30, 2026 03:11 WIB: Out of 134 US consumer cyclical stocks, 112 rose and 21 fell. Hyatt Hotels Corporation (H) gained 6.18% to USD 184.07 with a typical hold time of 150 days, while Lucid Group Inc (LCID) dropped 6.16% to USD 3.20, attracting 100% buy orders despite a shorter hold time of 46 days. Tapestry, Inc. (TPR) rose 6.08% to USD 118.00 but saw 82% sell activity and a typical hold time of 71 days.

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App